It may not be flashy or have big pharmaceutical backers, but an old, cheap and widely available steroid is showing it can keep some of the sickest coronavirus patients from dying, U.K. researchers say.
Medical experts who typically shy away from such language are hailing “breakthrough” results from a randomized controlled trial of the broad spectrum corticosteroid dexamethasone, which researchers said cut the risk of death for Covid-19 patients on ventilators by one-third.